We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Distinguishing Between Primary Endometrial and Cervical Cancer Diagnosis Using MRI

By MedImaging International staff writers
Posted on 24 May 2011
Magnetic resonance imaging (MRI) can determine if a patient has endometrial versus cervical cancer even when a biopsy cannot make that differentiation, according to a new study.

Determining the primary site of a tumor helps determine appropriate cancer treatment. The study, which was presented during the American Roentgen Ray Society annual meeting on May 3, 2011, in Chicago (IL, USA), found that radiologists using MRI could correctly identify the primary site of cancer in 79% of cases (38/48 patients) when biopsy results are inconclusive.

Endometrial and cervical cancers are common cancers in women, said Heather He, MD, PhD, from MD Anderson Cancer Center (Houston, TX, USA), where the study was conducted under the direction of Dr. Iyer and Dr. Bhosale. "In about 3% of the cases, there is difficulty determining the primary cancer site," she added. "Knowing the primary cancer site means that we can give the patients the most appropriate therapy and save some patients from unnecessary surgery," Dr. He said.

Two radiologists read the images as part of the study--one with five years experience and one with 18. Their diagnoses matched most of the time, which means that the readers' experience did not have much of an impact on the study results, explained Dr. He. "MRI can be applied on a broader scope; you don't have to have someone on staff with extensive experience to be able to offer this imaging service," she said.

The study also studied various MR sequences to determine which one was the most useful in making a diagnosis. "We found that sagittal T2 FSE weighted sequences and 2D [two-dimensional] and 3D T1-weighted dynamic enhanced sequences are the most helpful," Dr. He said.

Related Links:

MD Anderson Cancer Center



Biopsy Software
Affirm® Contrast
Adjustable Mobile Barrier
M-458
Digital Color Doppler Ultrasound System
MS22Plus
Digital Radiography System (Ceiling Free)
Digix CF Series

Channels

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.